Research / ANGI / Fundamental state Inspectable configuration
State dimensions Filing 0001705110-21-000058 General Corporate
Debt relative to revenue 92th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.debt_to_revenue
182.41% · OPTIONAL · VALID
Capex intensity 77th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.84% · OPTIONAL · VALID
Operating cash generation 0th Own-history percentile · N=12
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
3.96% · OPTIONAL · VALID
Revenue growth 33th Own-history percentile · N=9
Evidence method Yoy · gp.fundamentals.revenue
12.62% · CORE · VALID
Operating margin 46th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.operating_margin
0.03% · CORE · VALID
R&D intensity 38th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.66% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.53% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 31 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 6/6 normalized Level 3 Mar 31, 2022 6/6 normalized Level 3 Jun 30, 2022 6/7 normalized Level 3 Sep 30, 2022 6/7 normalized Level 3 Dec 31, 2022 6/7 normalized Level 3 Mar 31, 2023 6/7 normalized Level 3 Jun 30, 2023 6/7 normalized Level 3 Sep 30, 2023 6/7 normalized Level 3 Dec 31, 2023 5/6 normalized Level 3 Mar 31, 2024 5/6 normalized Level 3 Jun 30, 2024 6/6 normalized Level 3 Sep 30, 2024 6/6 normalized Level 3 Dec 31, 2024 6/6 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 6/6 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 49.05%
Current 182.41%
Delta 133.36% Capex Intensity Increased
Previous 3.58%
Current 4.84%
Delta 1.27% Cash Generation Decreased
Previous 12.84%
Current 3.96%
Delta -8.87% Growth Increased
Previous 10.69%
Current 12.62%
Delta 1.94% Profitability Increased
Previous -0.43%
Current 0.03%
Delta 0.46% R And D Intensity Decreased
Previous 4.69%
Current 4.66%
Delta -0.02% Sbc Intensity Decreased
Previous 5.70%
Current 0.53%
Delta -5.17% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.